
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Amgen (Switzerland), Switzerland, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
51%
Total
Publications
878
Total Open
Publications
451
Total
Citations
19K
Open Access
Percentage
51%
Total
Publications
878
Total Open
Publications
451
Total
Citations
19K
Breakdown
Publisher Open
23%
Both
26%
Other Platform Open
2%
Closed
49%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 23%
101
Hybrid 50%
217
No Guarantees 27%
114
Other Platform Open
Domain 66%
168
Institution 43%
110
Other Internet 26%
65
Public 3%
7
Preprint 1%
3
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 168 |
DOI | Other Internet | 59 |
Royal Netherlands Academy of Arts and Sciences | Institution | 24 |
Europe PMC | Domain | 16 |
Université Libre de Bruxelles | Institution | 10 |
Unknown Repository | Other Internet | 9 |
University of Milan | Institution | 9 |
University College of Arts Crafts and Design | Institution | 9 |
Imperial College London | Institution | 7 |
European Organization for Nuclear Research | Institution | 7 |